BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25403213)

  • 1. Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines.
    Stewart SB; Thompson RH; Psutka SP; Cheville JC; Lohse CM; Boorjian SA; Leibovich BC
    J Clin Oncol; 2014 Dec; 32(36):4059-65. PubMed ID: 25403213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach.
    Stewart-Merrill SB; Thompson RH; Boorjian SA; Psutka SP; Lohse CM; Cheville JC; Leibovich BC; Frank I
    J Clin Oncol; 2015 Dec; 33(35):4151-7. PubMed ID: 26351352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
    Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach.
    Stewart-Merrill SB; Boorjian SA; Thompson RH; Psutka SP; Cheville JC; Thapa P; Bergstrahl EJ; Tollefson MK; Frank I
    Urol Oncol; 2015 Aug; 33(8):339.e1-8. PubMed ID: 26031371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the National Comprehensive Cancer Network and European Society for Medical Oncology Nasopharyngeal Carcinoma Surveillance Guidelines.
    Zhou GQ; Lv JW; Tang LL; Mao YP; Guo R; Ma J; Sun Y
    Front Oncol; 2020; 10():119. PubMed ID: 32117766
    [No Abstract]   [Full Text] [Related]  

  • 6. Follow-up after curative treatment of localised renal cell carcinoma.
    Dabestani S; Marconi L; Kuusk T; Bex A
    World J Urol; 2018 Dec; 36(12):1953-1959. PubMed ID: 29767327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Usefulness of Chest X-Rays for T1a Renal Cell Carcinoma Surveillance.
    Canvasser NE; Stouder K; Lay AH; Gahan JC; Lotan Y; Margulis V; Raj GV; Sagalowsky AI; Cadeddu JA
    J Urol; 2016 Aug; 196(2):321-6. PubMed ID: 26880407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative surveillance imaging for patients undergoing nephrectomy for renal cell carcinoma.
    Kim EH; Strope SA
    Urol Oncol; 2015 Dec; 33(12):499-502. PubMed ID: 26411549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance Following Nephron-Sparing Surgery: An Assessment of Recurrence Patterns and Surveillance Costs.
    Zargar-Shoshtari K; Kim T; Simon R; Lin HY; Yue B; Sharma P; Spiess PE; Poch MA; Pow Sang J; Sexton WJ
    Urology; 2015 Aug; 86(2):321-6. PubMed ID: 26187013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Renal Cell Carcinoma Surveillance Guidelines: Competing Trade-Offs.
    Lobo JM; Nelson M; Nandanan N; Krupski TL
    J Urol; 2016 Jun; 195(6):1664-70. PubMed ID: 26778713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient Survival.
    Merrill SB; Sohl BS; Hamirani A; Lehman EB; Lehman KK; Kaag MG; Raman JD
    Clin Genitourin Cancer; 2019 Apr; 17(2):132-138. PubMed ID: 30563753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of national trends in the utilization of partial nephrectomy in relation to the publication of the American Urologic Association guidelines for the management of clinical T1 renal masses.
    Liss MA; Wang S; Palazzi K; Jabaji R; Patel N; Lee HJ; Parsons JK; Derweesh IH
    BMC Urol; 2014 Dec; 14():101. PubMed ID: 25519922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Surveillance Strategies After Surgery for Renal Cell Carcinoma.
    Tyson MD; Chang SS
    J Natl Compr Canc Netw; 2017 Jun; 15(6):835-840. PubMed ID: 28596262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol.
    Siddiqui SA; Frank I; Cheville JC; Lohse CM; Leibovich BC; Blute ML
    BJU Int; 2009 Sep; 104(6):778-85. PubMed ID: 19338559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance following surgery for nonmetastatic renal cell carcinoma.
    Richards KA; Abel EJ
    Curr Opin Urol; 2016 Sep; 26(5):432-8. PubMed ID: 27467135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma.
    Williamson TJ; Pearson JR; Ischia J; Bolton DM; Lawrentschuk N
    BJU Int; 2016 Apr; 117(4):555-62. PubMed ID: 26617405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic radiation exposure during surveillance in patients with pT1a renal cell carcinoma.
    Lipsky MJ; Shapiro EY; Hruby GW; McKiernan JM
    Urology; 2013 Jun; 81(6):1190-5. PubMed ID: 23540857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Utilization of Partial Nephrectomy Pre- and Post- AUA Guidelines: Is This as Good as It Gets?
    Sorokin I; Feustel PJ; O'Malley RL
    Clin Genitourin Cancer; 2017 Oct; 15(5):591-597.e1. PubMed ID: 28410908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Evaluation of the National Comprehensive Cancer Network and American Urological Association Renal Cell Carcinoma Surveillance Guidelines.
    Laguna MP
    J Urol; 2015 Jul; 194(1):43. PubMed ID: 26088219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.